Kee Moon to Antineoplastic Agents
This is a "connection" page, showing publications Kee Moon has written about Antineoplastic Agents.
Connection Strength
0.467
-
Park GH, Kim CH, Chung WK, Won CH, Chang SE, Lee MW, Choi JH, Moon KC. Primary cutaneous intravascular large B-cell lymphoma treated with combination chemotherapy and complicated by rituximab-induced interstitial lung disease. Acta Derm Venereol. 2010 May; 90(3):296-8.
Score: 0.222
-
Lee WJ, Moon IJ, Won CH, Chang SE, Choi JH, Moon KC, Lee MW. Facial swelling: an atypical presentation of cutaneous lymphoma. Int J Dermatol. 2016 Aug; 55(8):e440-6.
Score: 0.083
-
Lee WJ, Lee JH, Won CH, Chang SE, Choi JH, Moon KC, Kang YK, Lee MW. Clinical and histopathologic analysis of 46 cases of cutaneous adverse reactions to imatinib. Int J Dermatol. 2016 May; 55(5):e268-74.
Score: 0.082
-
Ahn SJ, Chang SE, Choi JH, Moon KC, Koh JK, Kim DY. A case of unresectable lymphangioma circumscriptum of the vulva successfully treated with OK-432 in childhood. J Am Acad Dermatol. 2006 Nov; 55(5 Suppl):S106-7.
Score: 0.044
-
Lee MW, Seo CW, Kim SW, Yang HJ, Lee HW, Choi JH, Moon KC, Koh JK. Cutaneous side effects in non-small cell lung cancer patients treated with Iressa (ZD1839), an inhibitor of epidermal growth factor. Acta Derm Venereol. 2004; 84(1):23-6.
Score: 0.036